Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03194958 · ClinicalTrials.gov registry record · NA
Helping Poor Smokers Quit
A NA study of Smoking Cessation and Smoking, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 1,944
- Enrollment target
- 1
- Study location
NCT03194958: Completed NA study of Smoking Cessation and Smoking, sponsored by Washington University School of Medicine.
NCT03194958 is a NA study of Smoking Cessation and Smoking that has completed, run by Washington University School of Medicine. The registered enrollment target is 1,944 participants, above the 464-participant average among 188 other Smoking Cessation trials with a reported enrollment target (319% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03194958, a NA study of Smoking Cessation and Smoking, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,944 participants
- Enrollment target
- 1
- Study location
Study Summary
Using a 2x2 randomized factorial design, we will conduct a statewide field trial in Missouri to compare the relative and combined effects of these two strategies for augmenting an existing, evidence-based tobacco quitline program. Among 2000 low-income smokers, half will receive standard Missouri quitline services and half will receive new Specialized Quitline services targeted to this group. In each of these groups, half also will receive calls from a trained navigator to help them address unmet Basic Needs and the accompanying psychological distress that act as barriers to smoking cessation.
Primary Outcome
Report 7-day point prevalence abstinence measured at 6-months post --baseline
Conditions Studied
Interventions
- BEHAVIORAL Specialized Quitline
- BEHAVIORAL Basic Needs Navigator
Study Locations (1)
Missouri
- Washington University in St. Louis - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,944 participants |
| Start Date | 2017-06-05 |
| Est. Completion | 2022-07-01 |
| Phase | NA |
What the finished NCT03194958 record still lists
NCT03194958 is an interventional study that assigns participants to a tested intervention. Its 1,944 participants enrollment target places it among the larger protocols in the corpus, above the 464-participant average among 188 other Smoking Cessation trials with a reported enrollment target (319% higher).
The record links to 10 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Specialized Quitline is the first listed.
NCT03194958 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT03194958 about?
NCT03194958 is a clinical study titled "Helping Poor Smokers Quit". Using a 2x2 randomized factorial design, we will conduct a statewide field trial in Missouri to compare the relative and combined effects of these two strategies for augmenting an existing, evidence-based tobacco quitline program. Among 2000 low-income smokers, half will receive standard Missouri qu...
What is the current status of trial NCT03194958?
This trial is currently completed. It is a NA study. The enrollment target is 1,944 participants. The study started on 2017-06-05. Estimated completion is 2022-07-01.
What conditions does trial NCT03194958 study?
This clinical trial studies the following conditions: Smoking Cessation, Smoking, Tobacco Use, Tobacco Smoking, Tobacco Use Cessation.
What interventions are being tested in trial NCT03194958?
The interventions under investigation include: Specialized Quitline (BEHAVIORAL), Basic Needs Navigator (BEHAVIORAL).
Who is sponsoring clinical trial NCT03194958?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03194958 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03194958's enrollment target sits among peer trials
1,944 9th of 188 higher than 180 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04251052 · 1,956 participants · NA
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- NCT05233150 · 1,932 participants · NA
Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)
- NCT06058455 · 1,920 participants · NA
An Evaluation of an Online Sexual Assault Resistance Program (IDEA3)
- NCT05174169 · 1,912 participants · Phase 2
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI